![]() |
|
|
Vol. 302, Issue 3, 1037-1045, September 2002
1 Subunit Knockout Mice
Departments of Pharmacology (J.E.K., A.L.M.) and Psychiatry
(A.L.M.), Bowles Center for Alcohol Studies (J.E.K., T.K.O., A.L.M.),
University of North Carolina, Chapel Hill, North Carolina; Department
of Pharmacology and Clinical Pharmacology, University of Turku, Turku,
Finland (E.R.K.); and Department of Anesthesiology, University of
Pittsburgh School of Medicine, Pittsburgh, Pennsylvania (G.E.H.)
GABAA receptors mediate fast inhibitory neurotransmission
in the central nervous system (CNS), and approximately half of these receptors contain
1 subunits. GABAA receptor
1
subunits are important for receptor assembly and specific
pharmacological responses to benzodiazepines. Plasticity in
GABAA receptor
1 subunit expression is associated with
changes in CNS excitability observed during normal brain
development, in animal models of epilepsy, and upon withdrawal
from alcohol and benzodiazepines. To examine the role of
1 subunit-containing GABAA receptors in vivo, we
characterized receptor subunit expression and pharmacological
properties in cerebral cortex of knockout mice with a targeted deletion
of the
1 subunit. The mice are viable but exhibit an intention
tremor. Western blot analysis confirms the complete loss of
1
subunit peptide expression. Stable adaptations in the expression of
several GABAA receptor subunits are observed in the fifth
to seventh generations, including decreased expression of
2/3 and
2 subunits and increased expression of
2 and
3 subunits.
There was no change in
4,
5, or
subunit peptide levels in
cerebral cortex. Knockout mice exhibit loss of over half of
GABAA receptors measured by [3H]muscimol,
[3H]2-(3-carboxyl)-3-amino-6-(4-methoxyphenyl)-pyridazinium
bromide ([3H]SR-95531), and
t-butylbicyclophosphoro[35S]thionate
([35S]TBPS) binding.
[3H]Ethyl-8-azido-5,6-dihydro-5-methyl-6-oxo-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylate ([3H]Ro15-4513) binding is reduced by variable amounts in
different regions across brain. GABAA receptor
1
/
mice lose all high-affinity
[3H]zolpidem binding and about half of
[3H]flunitrazepam binding in the cerebral cortex. The
potency and maximal efficacy of muscimol-stimulated
36Cl
uptake in cerebral cortical
synaptoneurosomes are reduced in
1
/
mice.
Furthermore, knockout mice exhibit increased bicuculline-induced seizure susceptibility compared with wild-type mice. These data emphasize the significance of
1 subunit expression and its
involvement in the regulation of CNS excitability.
This article has been cited by other articles:
![]() |
Y. Hu, I. V. Lund, M. C. Gravielle, D. H. Farb, A. R. Brooks-Kayal, and S. J. Russek Surface Expression of GABAA Receptors Is Transcriptionally Controlled by the Interplay of cAMP-response Element-binding Protein and Its Binding Partner Inducible cAMP Early Repressor J. Biol. Chem., April 4, 2008; 283(14): 9328 - 9340. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Zeller, F. Crestani, I. Camenisch, T. Iwasato, S. Itohara, J. M. Fritschy, and U. Rudolph Cortical Glutamatergic Neurons Mediate the Motor Sedative Action of Diazepam Mol. Pharmacol., February 1, 2008; 73(2): 282 - 291. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Liang, A. Suryanarayanan, A. Abriam, B. Snyder, R. W. Olsen, and I. Spigelman Mechanisms of Reversible GABAA Receptor Plasticity after Ethanol Intoxication J. Neurosci., November 7, 2007; 27(45): 12367 - 12377. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. P. Bonin, L. J. Martin, J. F. MacDonald, and B. A. Orser {alpha}5GABAA Receptors Regulate the Intrinsic Excitability of Mouse Hippocampal Pyramidal Neurons J Neurophysiol, October 1, 2007; 98(4): 2244 - 2254. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. R. Drasbek, K. Hoestgaard-Jensen, and K. Jensen Modulation of Extrasynaptic THIP Conductances by GABAA-Receptor Modulators in Mouse Neocortex J Neurophysiol, March 1, 2007; 97(3): 2293 - 2300. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. F. Maison, T. W. Rosahl, G. E. Homanics, and M. C. Liberman Functional Role of GABAergic Innervation of the Cochlea: Phenotypic Analysis of Mice Lacking GABAA Receptor Subunits {alpha}1, {alpha}2, {alpha}5, {alpha}6, beta2, beta3, or {delta} J. Neurosci., October 4, 2006; 26(40): 10315 - 10326. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. I. Ortinski, J. R. Turner, A. Barberis, G. Motamedi, R. P. Yasuda, B. B. Wolfe, K. J. Kellar, and S. Vicini Deletion of the GABAA Receptor {alpha}1 Subunit Increases Tonic GABAA Receptor Current: A Role for GABA Uptake Transporters J. Neurosci., September 6, 2006; 26(36): 9323 - 9331. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Krystal, J. Staley, G. Mason, I. L. Petrakis, J. Kaufman, R. A. Harris, J. Gelernter, and J. Lappalainen {gamma}-Aminobutyric Acid Type A Receptors and Alcoholism: Intoxication, Dependence, Vulnerability, and Treatment. Arch Gen Psychiatry, September 1, 2006; 63(9): 957 - 968. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Ponomarev, R. Maiya, M. T. Harnett, G. L. Schafer, A. E. Ryabinin, Y. A. Blednov, H. Morikawa, S. L. Boehm II, G. E. Homanics, A. Berman, et al. Transcriptional Signatures of Cellular Plasticity in Mice Lacking the {alpha}1 Subunit of GABAA Receptors J. Neurosci., May 24, 2006; 26(21): 5673 - 5683. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Gallagher, W. Shen, L. Song, and R. L. Macdonald Endoplasmic Reticulum Retention and Associated Degradation of a GABAA Receptor Epilepsy Mutation That Inserts an Aspartate in the M3 Transmembrane Segment of the {alpha}1 Subunit J. Biol. Chem., November 11, 2005; 280(45): 37995 - 38004. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. W. J. Bosman, K. Heinen, S. Spijker, and A. B. Brussaard Mice Lacking the Major Adult GABAA Receptor Subtype Have Normal Number of Synapses, But Retain Juvenile IPSC Kinetics Until Adulthood J Neurophysiol, July 1, 2005; 94(1): 338 - 346. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Sonner, M. Cascio, Y. Xing, M. S. Fanselow, J. E. Kralic, A. L. Morrow, E. R. Korpi, S. Hardy, B. Sloat, E. I. Eger II, et al. {alpha}1 Subunit-Containing GABA Type A Receptors in Forebrain Contribute to the Effect of Inhaled Anesthetics on Conditioned Fear Mol. Pharmacol., July 1, 2005; 68(1): 61 - 68. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. R. Isles, W. Davies, D. Burrmann, P. S. Burgoyne, and L. S. Wilkinson Effects on fear reactivity in XO mice are due to haploinsufficiency of a non-PAR X gene: implications for emotional function in Turner's syndrome Hum. Mol. Genet., September 1, 2004; 13(17): 1849 - 1855. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Fagiolini, J.-M. Fritschy, K. Low, H. Mohler, U. Rudolph, and T. K. Hensch Specific GABAA Circuits for Visual Cortical Plasticity Science, March 12, 2004; 303(5664): 1681 - 1683. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J Whelan Developmental aspects of spinal locomotor function: insights from using the in vitro mouse spinal cord preparation J. Physiol., December 15, 2003; 553(3): 695 - 706. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. S. Findlay, R. Phelan, M. T. Roberts, G. E. Homanics, S. E. Bergeson, G. F. Lopreato, S. J. Mihic, Y. A. Blednov, and R. A. Harris Glycine Receptor Knock-In Mice and Hyperekplexia-Like Phenotypes: Comparisons with the Null Mutant J. Neurosci., September 3, 2003; 23(22): 8051 - 8059. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. A. Blednov, D. Walker, H. Alva, K. Creech, G. Findlay, and R. A. Harris GABAA Receptor {alpha}1 and {beta}2 Subunit Null Mutant Mice: Behavioral Responses to Ethanol J. Pharmacol. Exp. Ther., June 1, 2003; 305(3): 854 - 863. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Kralic, M. Wheeler, K. Renzi, C. Ferguson, T. K. O'Buckley, A. C. Grobin, A. L. Morrow, and G. E. Homanics Deletion of GABAA Receptor alpha 1 Subunit-containing Receptors Alters Responses to Ethanol and Other Anesthetics J. Pharmacol. Exp. Ther., May 1, 2003; 305(2): 600 - 607. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. A. Blednov, S. Jung, H. Alva, D. Wallace, T. Rosahl, P.-J. Whiting, and R. A. Harris Deletion of the alpha 1 or beta 2 Subunit of GABAA Receptors Reduces Actions of Alcohol and Other Drugs J. Pharmacol. Exp. Ther., January 1, 2003; 304(1): 30 - 36. [Abstract] [Full Text] [PDF] |
||||